“Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies”, J of Skin, vol. 3, no. 2, p. 161, Mar. 2019, doi: 10.25251/skin.3.2.1.